The CUREator+ Dementia and Cognitive Decline incubator program is a partnership between Brandon BioCatalyst, ANDHealth and Dementia Australia.

Expressions of interest (EOI) for Round 2 of CUREator+ Dementia & Cognitive Decline will be open from 21 May 2025 to 10 July 2025 (1:00 pm AEST).

Designed to support innovative solutions with the potential to improve the lives of Australians affected by dementia, the program is seeking startups and companies focused on expanding treatment and wellbeing options for the 433,000 Australians living with dementia and the 1.7 million carers who support them.

Up to $5 million is available for eligible projects, including the development of assistive devices, digital technology approaches and products, novel biomarkers, diagnostics and therapeutics.

Projects must support the development of technologies that: lead to the early diagnosis of dementia, prevent the severity of progression and/or manage the symptoms of dementia, and/or promote enabling environments to increase safety and quality of life for people living with dementia and cognitive decline.

Attend this information session to learn more about the program, eligibility and application process.

Date: Thursday 29 May 2025
Time: 12:00 pm – 1:00 pm (AEST)
Online via Zoom: https://andhealth-au.zoom.us/j/87143245780

CUREator+ Dementia & Cognitive Decline is funded by the Australian Government Department of Health, Disability and Ageing MRFF BioMedTech Incubator Program

Contact the host of CUREator+ Dementia & Cognitive Decline Round 2 Information Session